Positron Corp. is a molecular imaging company focusing on nuclear cardiology and utilizing its proprietary product line to provide unique solutions to the Nuclear Medicine community. The company's products and services range from imaging systems to radio-pharmaceutical distribution. The main products of the company are: the Attrius, a PET imaging device; the Pulse, a SPECT imaging device; the Nuclear Pharm-Assist, an automated radiopharmaceutical distribution device; and the Tech-Assist, a radio-pharmaceutical injection shield. Positron Corporation is the only company in North America that offers a standalone, dedicated cardiac reasonably priced PET system. Through its China based joint venture, Neusoft Positron Medical Systems, Positron Corp. has upgraded its PET imaging system to accommodate the growing need for less expensive, high quality molecular imaging devices in today's challenging economy. Positron's technology for PET imaging provides image quality comparable to other PET manufactures with a fraction of their price. In addition, Positron offers a software patient management solution to improve patient care. The AttriusTM Cardiac PET system has received FDA approval in 2009. Positron Corp. was founded in 1983.
After closing up 15.70% on Friday, Positron Corporation (OTC:POSC) managed to add another 21.43% yesterday. Both sessions the volume was high above the average.read more
Positron Corporation (OTC:POSC) cut off the climb again. Yesterday, the stock lost 37.88% of its price, while its traded volume jumped over 11 million shares.read more
Positron Corporation (OTC:POSC) has been promoted since Saturday, though currently its stock price is falling down. After a spectacular gain on Monday, POCS started moving down again with no reasonable explanation.read more
Stock price of Positron Corporation (OTC:POSC) has been quite unstable over the past week. After a jump up, the climb was suddenly broken and POSC lost 7.41% on Thursday.read more
This week Positron Corporation (OTC:POSC) has aimed the top of the chart. Yesterday, the stock continued to climb up and soared another 10% on the market. Besides, its traded volume increased even more to reach 9.7 million shares for the day.read more
MC Members,
POSC is up over 14% this morning with almost 3 million shares traded this morning.
This represents an increase in volume of more than 60% over 3 month averages so far today!
Momentum is clearly building for POSC and as more and more investors begin to look more closely at POSC, and volume continues to climb, POSC could potentially push past historic highs representing gains of over read more
PSP Free Members,
POSC has reached a mid day high at .0164, and is currently trading at .016 up over 14% from yesterday's closing price!
POSC has traded nearly 3 million shares so far on the early morning news that the company has entered into a binding letter of intent with Manhattan Isotope Technology (MIT) to make MIT a wholly owned subsidiary of POSC!
(Read More)
This is a strategic step in POSC coming to a definitive read more
PSP Free Members,
We are coming upon the Thanksgiving holiday in just a week, and I want you to be reminded of just a few of the stock ideas to be thankful for from this past year:
STEV: $0.89 (pick price) to $1.04 (high) 16% gain potential
NYXO: $0.58 (pick price) to $1.13 (high) 94% gain potential
SHMX: $0.0440 (pick price) to $0.0810 (high) 84% gain potential
GSTP: $0.11 (pick price) to $0.15 (high) 36% gain potential
HOTM: $0.72 read more